liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
How to design the cost‐effectiveness appraisal process of new healthcare technologies to maximise population health: A conceptual framework
Linköping University, Department of Medical and Health Sciences, Division of Health Care Analysis. Linköping University, Faculty of Medicine and Health Sciences.
Centre for Health Economics, University of York, York, UK.
Centre for Health Economics, University of York, York, UK.
Health Economics and Decision Science, University of Sheffield, Sheffield, UK.
2017 (English)In: Health Economics, ISSN 1057-9230, E-ISSN 1099-1050Article in journal (Refereed) Published
Abstract [en]

This paper presents a conceptual framework to analyse the design of the cost‐effectiveness appraisal process of new healthcare technologies. The frameworkcharacterises the appraisal processes as a diagnostic test aimed at identifyingcost‐effective (true positive) and non‐cost‐effective (true negative) technologies.Using the framework, factors that influence the value of operating an appraisalprocess, in terms of net gain to popula tion health, are identified. The frame-work is used to gain insight into current policy questions including (a) howrigorous the process should be, (b) who should have the burden of proof, and(c) how optimal design changes when allowing for appeals, price reductions,resubmissions, and re‐evaluations.The paper demonstrates that there is no one optimal appraisal process and theprocess should be adapted over time and to the specific technology underassessment. Optimal design depends on country‐specific features of (future)technologies, for example, effect, price, and size of the patient population,which might explain the difference in appraisal processes across countries. Itis shown that burden of pro of should be placed on the producers and that theimpact of price reductions and patient access schemes on the producer's pricesetting should be considered when designing the appraisal process.

Place, publisher, year, edition, pages
John Wiley & Sons, 2017.
Keyword [en]
cost‐effectiveness appraisal and decision making, economic evaluation, health technology appraisal
National Category
Health Sciences
Identifiers
URN: urn:nbn:se:liu:diva-140899DOI: 10.1002/hec.3561OAI: oai:DiVA.org:liu-140899DiVA: diva2:1141412
Available from: 2017-09-14 Created: 2017-09-14 Last updated: 2017-10-06

Open Access in DiVA

The full text will be freely available from 2018-08-22 09:51
Available from 2018-08-22 09:51

Other links

Publisher's full text

Search in DiVA

By author/editor
Johannesen, Kasper M
By organisation
Division of Health Care AnalysisFaculty of Medicine and Health Sciences
In the same journal
Health Economics
Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 34 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf